Latest EBS reports update at 2024-03-08: 2023 ∙ 2022 ∙ 2021

Emergent BioSolutions EBS

$ 4.37 -0.91%

Emergent BioSolutions Balance Sheet 2011-2024 | EBS

Annual Balance Sheet Emergent BioSolutions

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	338 M	-188 M	239 M	254 M	644 M	682 M	-165 M	-3.42 M	-59.8 M	-29.5 M	-117 M	-78.9 M	-84.4 M
Long Term Debt	446 M	448 M	809 M	841 M	798 M	784 M	13.5 M	248 M	253 M	251 M	62 M	58.3 M	54.1 M
Long Term Debt Current	3.5 M	5.8 M	5.8 M	33.8 M	12.9 M	10.1 M	-	-	-	-	-	4.47 M	-
Total Non Current Liabilities	-	-	-	-	1.02 B	1.02 B	57.8 M	268 M	284 M	299 M	80.8 M	60.2 M	59.1 M
Total Current Liabilities	651 M	1.23 B	374 M	384 M	216 M	200 M	100 M	106 M	99.6 M	92.9 M	56.7 M	61.9 M	71.1 M
Total Liabilities	1.17 B	1.78 B	1.35 B	1.44 B	1.24 B	1.22 B	158 M	374 M	384 M	392 M	137 M	122 M	130 M
Deferred Revenue	27.2 M	26.4 M	11.7 M	-	-	10.6 M	13.2 M	7.04 M	7.94 M	5.34 M	1.83 M	1.81 M	1.36 M
Retained Earnings	-21.8 M	739 M	950 M	727 M	422 M	367 M	337 M	254 M	351 M	288 M	252 M	220 M	197 M
Total Assets	1.82 B	3.17 B	2.96 B	2.88 B	2.33 B	2.23 B	1.07 B	970 M	1.04 B	945 M	627 M	564 M	547 M
Cash and Cash Equivalents	112 M	643 M	576 M	621 M	168 M	112 M	178 M	272 M	313 M	280 M	179 M	142 M	144 M
Book Value	649 M	1.39 B	1.61 B	1.45 B	1.09 B	1.01 B	912 M	596 M	660 M	553 M	489 M	442 M	417 M
Total Shareholders Equity	649 M	1.39 B	1.61 B	1.45 B	1.09 B	1.01 B	912 M	596 M	660 M	553 M	490 M	441 M	414 M

All numbers in USD currency

Quarterly Balance Sheet Emergent BioSolutions

	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	448 M	448 M	1.03 B	-	802 M	809 M	817 M	825 M	833 M	841 M	841 M	841 M	841 M	798 M	798 M	798 M	798 M	784 M	784 M	784 M	784 M	13.5 M	13.5 M	13.5 M	13.5 M	248 M	248 M	248 M	248 M	247 M	247 M	247 M	247 M	251 M	251 M	251 M	251 M	62 M	62 M	62 M	62 M	58.3 M	58.3 M	58.3 M	58.3 M	54.1 M	54.1 M	54.1 M	54.1 M
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	1.2 B	1.78 B	1.46 B	-	1.21 B	1.34 B	1.34 B	1.37 B	1.38 B	1.44 B	1.44 B	1.44 B	1.44 B	1.24 B	1.24 B	1.24 B	1.24 B	1.22 B	1.22 B	1.22 B	1.22 B	158 M	158 M	158 M	158 M	374 M	374 M	374 M	374 M	377 M	377 M	377 M	377 M	385 M	385 M	385 M	392 M	137 M	137 M	137 M	137 M	122 M	122 M	122 M	122 M	130 M	130 M	130 M	130 M
Deferred Revenue	22.9 M	26.4 M	-	-	10 M	11.7 M	36.8 M	54.5 M	60.3 M	44.6 M	44.6 M	44.6 M	44.6 M	3.3 M	-	3.3 M	-	10.6 M	10.8 M	9.75 M	6.96 M	13.2 M	4.51 M	15.4 M	10.6 M	7.04 M	7.04 M	7.04 M	7.04 M	3.98 M	3.98 M	7.94 M	7.94 M	5.34 M	5.34 M	5.34 M	5.34 M	1.83 M	1.83 M	1.83 M	1.83 M	1.81 M	1.81 M	1.81 M	1.81 M	1.36 M	1.36 M	1.36 M	1.36 M
Retained Earnings	27.7 M	739 M	806 M	-	954 M	958 M	768 M	801 M	797 M	727 M	727 M	727 M	727 M	422 M	422 M	422 M	422 M	367 M	367 M	367 M	367 M	337 M	337 M	337 M	337 M	254 M	254 M	254 M	254 M	351 M	351 M	351 M	351 M	288 M	288 M	288 M	288 M	252 M	252 M	252 M	252 M	220 M	220 M	220 M	220 M	197 M	197 M	197 M	197 M
Total Assets	1.89 B	3.17 B	2.9 B	-	2.78 B	2.96 B	2.87 B	2.92 B	2.9 B	2.88 B	2.88 B	2.88 B	2.88 B	2.33 B	2.33 B	2.33 B	2.33 B	2.23 B	2.23 B	2.23 B	2.23 B	1.07 B	1.07 B	1.07 B	1.07 B	970 M	970 M	970 M	970 M	1.04 B	1.04 B	1.04 B	1.04 B	939 M	939 M	939 M	945 M	627 M	627 M	627 M	627 M	564 M	564 M	564 M	564 M	547 M	547 M	547 M	547 M
Cash and Cash Equivalents	87.8 M	643 M	241 M	-	436 M	576 M	404 M	448 M	548 M	621 M	621 M	621 M	621 M	168 M	168 M	168 M	168 M	112 M	112 M	112 M	112 M	178 M	178 M	178 M	178 M	272 M	272 M	272 M	272 M	313 M	313 M	313 M	313 M	280 M	280 M	280 M	280 M	179 M	179 M	179 M	179 M	142 M	142 M	142 M	142 M	144 M	144 M	144 M	144 M
Book Value	697 M	1.39 B	1.43 B	-	1.58 B	1.62 B	1.52 B	1.54 B	1.52 B	1.45 B	1.45 B	1.45 B	1.45 B	1.09 B	1.09 B	1.09 B	1.09 B	1.01 B	1.01 B	1.01 B	1.01 B	912 M	912 M	912 M	912 M	596 M	596 M	596 M	596 M	660 M	660 M	660 M	660 M	553 M	553 M	553 M	553 M	489 M	489 M	489 M	489 M	442 M	442 M	442 M	442 M	417 M	417 M	417 M	417 M
Total Shareholders Equity	697 M	1.39 B	1.43 B	-	1.58 B	1.62 B	1.52 B	1.54 B	1.52 B	1.45 B	1.45 B	1.45 B	1.45 B	1.09 B	1.09 B	1.09 B	1.09 B	1.01 B	1.01 B	1.01 B	881 M	912 M	912 M	912 M	912 M	596 M	596 M	596 M	596 M	660 M	660 M	660 M	660 M	553 M	513 M	488 M	477 M	490 M	490 M	490 M	490 M	441 M	441 M	441 M	441 M	414 M	414 M	414 M	414 M

All numbers in USD currency